⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20214586 | 0.94 | — | — | |
| SCHEMBL25680130 | 0.87 | STING1 (0.34) | — | |
| SCHEMBL20214363 | 0.82 | TYMP (0.45) | — | |
| SCHEMBL21074015 | 0.82 | TYMP (0.31) | — | |
| SCHEMBL21074014 | 0.80 | MEN1 (0.30) | — | |
| SCHEMBL25495885 | 0.77 | — | — | |
| SCHEMBL25680132 | 0.74 | PNP (0.40) | — | |
| SCHEMBL20214481 | 0.73 | ADK (0.37) | — | |
| SCHEMBL21073968 | 0.71 | — | — | |
| SCHEMBL25495879 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066047-A1 | ANTIBODY-DRUG CONJUGATES COMPRISING A CYCLIC DINUCLEOTIDE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-02-29 | — | — | US | disclosed |
| US-11666594-B2 | Antibody-drug conjugates comprising a cyclic dinucleotide | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-06-06 | — | — | US | disclosed |